GB2368642B - Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response - Google Patents

Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response

Info

Publication number
GB2368642B
GB2368642B GB0203838A GB0203838A GB2368642B GB 2368642 B GB2368642 B GB 2368642B GB 0203838 A GB0203838 A GB 0203838A GB 0203838 A GB0203838 A GB 0203838A GB 2368642 B GB2368642 B GB 2368642B
Authority
GB
United Kingdom
Prior art keywords
activation
treating
detecting
conditions associated
monitoring conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0203838A
Other versions
GB0203838D0 (en
GB2368642A (en
Inventor
David E Berg
Lois Hill Berg
Harold H Harrison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB0203838D0 publication Critical patent/GB0203838D0/en
Publication of GB2368642A publication Critical patent/GB2368642A/en
Application granted granted Critical
Publication of GB2368642B publication Critical patent/GB2368642B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/224—Haemostasis or coagulation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/306—Chronic fatigue syndrome

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
GB0203838A 1999-08-13 2000-08-11 Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response Expired - Fee Related GB2368642B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14879999P 1999-08-13 1999-08-13
PCT/US2000/022177 WO2001012839A1 (en) 1999-08-13 2000-08-11 Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response

Publications (3)

Publication Number Publication Date
GB0203838D0 GB0203838D0 (en) 2002-04-03
GB2368642A GB2368642A (en) 2002-05-08
GB2368642B true GB2368642B (en) 2004-07-07

Family

ID=22527442

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0203838A Expired - Fee Related GB2368642B (en) 1999-08-13 2000-08-11 Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response

Country Status (4)

Country Link
AU (1) AU783760B2 (en)
CA (1) CA2385502C (en)
GB (1) GB2368642B (en)
WO (1) WO2001012839A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005520170A (en) * 2001-06-29 2005-07-07 バイオメリュー・インコーポレイテッド Method for predicting increased likelihood of antiphospholipid syndrome in patients
JP2010271078A (en) 2009-05-19 2010-12-02 Mcbi:Kk Biomarker of mental disorder containing cognitive disorder, and method of detecting mental disorder containing cognitive disorder using biomarker
DE202022106913U1 (en) 2022-12-09 2023-01-04 Kusum Yadav Cardiovascular disease detection system based on machine learning using IoT sensors

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834215A (en) * 1994-10-05 1998-11-10 The Administrators Of The Tulane Educational Fund Method for detecting antipolymer antibodies and diagnosing silicone related disease (SRD) fibromyalgia and chronic fatigue syndrome (CFS)
US5846758A (en) * 1995-11-30 1998-12-08 His Excellency Ghassan I. Shaker Method for diagnosing autoimmune diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834215A (en) * 1994-10-05 1998-11-10 The Administrators Of The Tulane Educational Fund Method for detecting antipolymer antibodies and diagnosing silicone related disease (SRD) fibromyalgia and chronic fatigue syndrome (CFS)
US5846758A (en) * 1995-11-30 1998-12-08 His Excellency Ghassan I. Shaker Method for diagnosing autoimmune diseases

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Arterioscler. Thromb. Vasc. Biol. Vol. 15, No. 2, Feb. 1995, pages 241 - 246. *
Blood Coagulation & Fibrinolysis Vol. 10, No. 7, October 1999, pages 435 - 438. *
Blood Coagulation & Fibrinolysis Vol.4, No. 3, 1993, pages 435 - 439. *
Blood Vol. 90, No. 10, 1997, Suppl. 1, Part 2, page 111b, Abstract No. 3206 & 3207. *
British Heart Journal Vol. 73, No. 6, 1995, pages 527 - 533. *
Canadian Med. Association J. Vol. 157, No. 6, Sept. 1997, pages 673 - 681. *
International J. Clin. Lab. Research Vol. 21, No. 2, 1991, pages 165 - 170. *
Merck Manual of Diagnosis & Therapy 16th Edition, 1992, pages 154 - 157; 678 - 679; 841 - 845; 1312 - 1313; 1402 - 1407; 1488 - 1490; 1495 - 1500; 2102 - 2105; 2267 - 2268. *
Stroke Vol. 25, No. 2, Feb. 1994, pages 282 - 286. *

Also Published As

Publication number Publication date
WO2001012839A1 (en) 2001-02-22
AU783760B2 (en) 2005-12-01
CA2385502C (en) 2010-10-19
CA2385502A1 (en) 2001-02-22
GB0203838D0 (en) 2002-04-03
GB2368642A (en) 2002-05-08
AU6769000A (en) 2001-03-13

Similar Documents

Publication Publication Date Title
MXPA01012351A (en) Method and apparatus improving performance of aperture monitoring system.
ZA983105B (en) Methods and apparatuses for monitoring or controlling pests.
DE60225443D1 (en) SECURITY UNIT, CONTROL CHAIN PROCEDURE, CONTROL SYSTEM CONTROL METHOD, AND CONTROL SYSTEM MONITORING PROCESS
AU3699700A (en) Monitoring system and method
HK1096483A1 (en) Emotion detecting method and system of the same
HK1035651A1 (en) Method and arrangement for heartbeat detection
AU2003280259A8 (en) Method, device and system for detecting the presence of microorganisms
AU2002320100A1 (en) Methods for detecting and treating the early onset of aging-related conditions
GB2379749A8 (en) Process control system with monitoring
DE60031947D1 (en) Blood treatment method with associated detection methods
GB9908960D0 (en) Method and system for electroseismic monitoring of microseismicity
HK1045387A1 (en) Compliance monitoring for anomaly detection
AU3467300A (en) Method for treating glaucoma, device for realising the same and variants
AU2002311981A1 (en) System and method for monitoring or treating a health condition
EP1015038A4 (en) Methods for the detection, treatment, and prevention of neurodegeneration
DE69738007D1 (en) Gas sensor, method for monitoring the gas sensor and the gas concentration
ID26243A (en) PROCESS FOR BUTANEDIOL, BUTIROLAKTON AND TETRAHIDROFURAN PROCESS
GB2368642B (en) Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response
EP0992549A4 (en) Antifouling agent, method for antifouling treatment, and article obtained through antifouling treatment
GB9908737D0 (en) Machine condition monitoring apparatus and method
DE69912904D1 (en) Labeled cojugate and detection method using the same
GB9907098D0 (en) Vehicle monitoring and control
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
GB9821001D0 (en) Process monitoring and control methods
EP1210595A4 (en) System for monitoring the expression and/or location of transgenes

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20130811